Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/1998
09/22/1998CA2086434C Quinuclidine derivatives
09/22/1998CA1340055C Process for the preparation of tertiary carbinols containing an aminic substituent
09/20/1998CA2232467A1 Imidazoles with serotonin receptor binding activity
09/19/1998CA2224128A1 Cdna clone hnfdy20 that encodes a novel human 7-transmembrane receptor
09/17/1998WO1998040482A1 Growth factor receptor binding protein
09/17/1998WO1998040404A2 Secreted proteins and polynucleotides encoding them
09/17/1998WO1998040386A1 Dioxino derivatives and their use as therapeutic agents
09/17/1998WO1998040344A1 2-substituted benzoyl-cycloalkyl-1-carboxylic acid derivatives
09/17/1998WO1998040072A1 Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders
09/17/1998WO1998040071A1 Identification of agents for use in the treatment of alzheimer's disease
09/17/1998WO1998040070A1 Compositions containing capsaicin or capsaicin analogues and a local anesthetic
09/17/1998WO1998040061A1 Use of r-nsaid's for the prevention of alzheimer's disease
09/17/1998WO1998040060A1 Solid, non-deliquescent formulations of sodium valproate
09/17/1998WO1998040055A2 Anti-epileptogenic agents
09/17/1998WO1998039967A1 A method for treating or preventing alzheimer's disease
09/17/1998WO1998030683A3 Nuclear transfer with differentiated fetal and adult donor cells
09/17/1998WO1998025594A3 Lamotrigine in the treatment and prophylaxis of migraine
09/17/1998WO1998024905A3 Secreted proteins and polynucleotides encoding them
09/17/1998WO1998007850A3 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans
09/17/1998DE19805370A1 New aromatic amino compounds
09/17/1998DE19711053A1 Kombinationspräparat aus 2-Methyl-thiazolidin-2,4-dicarbonsäure und Paracetamol Combination preparation of 2-methyl-thiazolidine-2,4-dicarboxylic acid and acetaminophen
09/17/1998CA2521212A1 Anti-epileptogenic agents
09/17/1998CA2323889A1 A method for treating or preventing alzheimer's disease
09/17/1998CA2283313A1 Anti-epileptogenic agents
09/17/1998CA2283296A1 Growth factor receptor binding protein
09/17/1998CA2283227A1 Medicinal preparation containing a lipophilic inert gas
09/17/1998CA2283193A1 Secreted proteins and polynucleotides encoding them
09/17/1998CA2283184A1 2-substituted benzoyl-cycloalkyl-1-carboxylic acid derivatives
09/17/1998CA2254078A1 Solid, non-deliquescent formulations of sodium valproate
09/16/1998EP0864559A1 Substituted amino compounds and their use as analgesic active substances
09/16/1998EP0864087A1 Combinatorial dihydrobenzopyran library
09/16/1998EP0863992A1 Product and process to regulate actin polymerization
09/16/1998EP0863904A2 Novel spiro 2h-1-benzopyran-2,4'-piperidine]- 4(3h)-one derivatives, acid addition salts thereof and pharmaceutical compositions containing them
09/16/1998EP0863891A1 (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors
09/16/1998EP0863883A1 Alpha-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors
09/16/1998EP0863882A1 Amino substituted pyrimidines and triazines
09/16/1998EP0863881A1 Benzimidazole derivatives and their use in the prevention and/or the treatment of bone diseases
09/16/1998EP0863870A1 Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents
09/16/1998EP0863760A1 Use of antimineralocorticoid compounds against drug withdrawal syndrome
09/16/1998EP0863759A1 Use of a combination of pentoxifylline and type i interferons for treating multiple sclerosis
09/16/1998EP0863756A1 Use of 2-iminobenzothiazolines for treating parkinson's disease and parkinsonian syndromes
09/16/1998EP0733047B1 Substituted oxazolidines with stimulating effect of beta-adrenergig receptor
09/16/1998EP0728128B1 Substituted phenyl compounds
09/16/1998EP0724637B1 Corticotropin-releasing factor 2 receptors
09/16/1998EP0710230B1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists
09/16/1998EP0654023B1 5-(2-oxyphenyl)-pyrrole derivatives as dopamine d3 receptor antagonists
09/16/1998EP0530265B1 Dna encoding human 5-ht 1d receptors and uses thereof
09/16/1998CN1192913A Shentong capsule and preparing method thereof
09/16/1998CN1192908A Scorpion-venom injecta, preparation method and use method therefor
09/16/1998CN1192904A Composite preparation for treatment of dementia
09/16/1998CN1192903A Medicine of diguanidino-prine-hydride compounds for giving up drug-taking
09/15/1998US5808151 Biphenylamido derivatives as melatonergic agents
09/15/1998US5807951 Pharmaceutical composition regulating function of a living body
09/15/1998US5807897 Aminotetralin derivative and compositions and method of use thereof
09/15/1998US5807889 Aminomethylindans, -benzofuranes and -benzothiophenes
09/15/1998US5807886 Treatment of neurodegenerative disorders, migraine, drug addiction
09/15/1998US5807885 Amidine derivatives with nitric oxide synthetase activities
09/15/1998US5807871 Psychological disorders, alzheimer or parkinson disease
09/15/1998US5807868 Analgesics; psychological disordes; parkinson*s diesase;cognition activators; drug dependence; dyskinesia
09/15/1998US5807867 Quinuclidine derivatives
09/15/1998US5807862 Therapeutic compounds containing pyrimidinyl moieties
09/15/1998US5807859 Antiischemic agents; brain disorders
09/15/1998US5807857 Migraine
09/15/1998US5807855 1-piperazino-1,2-dihydroindene derivatives
09/15/1998US5807851 2,3-Benzodiazepine Derivatives as non-competitive AMPA
09/15/1998US5807849 Therapeutic methods and delivery systems utilizing sex steroid precursors
09/15/1998US5807847 Nitrate esters
09/15/1998US5807826 Semaphorin gene family
09/15/1998US5807824 C5A receptor antagonists having substantially no agonist activity
09/15/1998US5807689 Bioanalysis
09/15/1998US5807570 Dopamine agonist
09/11/1998WO1998039463A2 Lentivirus based vector and vector system
09/11/1998WO1998039429A2 Compositions for treatment of disorders involving programmed cell death
09/11/1998WO1998039329A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
09/11/1998WO1998039327A1 Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid
09/11/1998WO1998039301A1 1-(isoquinolin-1-yl)-4-(1-phenylmethyl)piperazines; dopamine receptor subtype specific ligands
09/11/1998WO1998039284A1 Aryl- and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity
09/11/1998WO1998039018A1 Plant extract compositions, method of preparation, and pharmaceutical compositions containing them
09/11/1998WO1998039005A1 Pharmaceutical composition for the treatment of so-called restless legs
09/11/1998WO1998039000A1 Use of cholinesterase inhibitors to treat disorders of attention
09/11/1998WO1998038999A1 The use of levobupivacaine in paediatric surgery
09/11/1998WO1998038998A1 The use of levobupivacaine or ropivacaine in treating migraine
09/11/1998WO1998038996A1 The use of levobupivacaine in facial surgery
09/11/1998WO1998038994A2 Combined preparation of 2-methylthiazolidine-2,4-dicarboxylic acid and paracetamol
09/11/1998WO1998038988A1 Use of pivagabin to prepare pharmaceutical compositions
09/11/1998WO1998038983A2 Swallow tablet comprising paracetamol
09/11/1998WO1998038859A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
09/11/1998WO1998030707A3 Eukaryotic gene expression cassette and uses thereof
09/11/1998WO1998016238A3 Cancer immunotherapy using tumor cells combined with mixed lymphocytes
09/11/1998CA2285405A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
09/11/1998CA2283415A1 Aryl- and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity
09/11/1998CA2283275A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
09/11/1998CA2283272A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
09/11/1998CA2283256A1 1-(isoquinolin-1-yl)-4-(1-phenylmethyl)piperazines; dopamine receptor subtype specific ligands
09/11/1998CA2283145A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/11/1998CA2283122A1 Plant extract compositions, method of preparation, and pharmaceutical compositions containing them
09/11/1998CA2282851A1 Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid
09/11/1998CA2282827A1 Method of alleviating neuropathic pain
09/11/1998CA2282399A1 Thioaryl sulfonamide hydroxamic acid compounds
09/11/1998CA2282318A1 N-hydroxy 4-sulfonyl butanamide compounds
1 ... 1580 1581 1582 1583 1584 1585 1586 1587 1588 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 ... 1833